115 related articles for article (PubMed ID: 34237432)
1. Lysophosphatidylglucoside is a GPR55 -mediated chemotactic molecule for human monocytes and macrophages.
Li X; Hanafusa K; Kage M; Yokoyama N; Nakayama H; Hotta T; Oshima E; Kano K; Matsuo I; Nagatsuka Y; Takamori K; Ogawa H; Hirabayashi Y; Iwabuchi K
Biochem Biophys Res Commun; 2021 Sep; 569():86-92. PubMed ID: 34237432
[TBL] [Abstract][Full Text] [Related]
2. Lysophosphatidylglucoside/GPR55 signaling promotes foam cell formation in human M2c macrophages.
Shimai R; Hanafusa K; Nakayama H; Oshima E; Kato M; Kano K; Matsuo I; Miyazaki T; Tokano T; Hirabayashi Y; Iwabuchi K; Minamino T
Sci Rep; 2023 Aug; 13(1):12740. PubMed ID: 37544935
[TBL] [Abstract][Full Text] [Related]
3. GPR55 contributes to neutrophil recruitment and mechanical pain induction after spinal cord compression in mice.
Ono T; Yamashita T; Kano R; Inoue M; Okada S; Kano K; Koizumi S; Iwabuchi K; Hirabayashi Y; Matsuo I; Nakashima Y; Kamiguchi H; Kohro Y; Tsuda M
Brain Behav Immun; 2023 May; 110():276-287. PubMed ID: 36898418
[TBL] [Abstract][Full Text] [Related]
4. Lysophosphatidylinositol Promotes Chemotaxis and Cytokine Synthesis in Mast Cells with Differential Participation of GPR55 and CB2 Receptors.
Martínez-Aguilar LM; Ibarra-Sánchez A; Guerrero-Morán DJ; Macías-Silva M; Muñoz-Bello JO; Padilla A; Lizano M; González-Espinosa C
Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047288
[TBL] [Abstract][Full Text] [Related]
5. A role for L-alpha-lysophosphatidylinositol and GPR55 in the modulation of migration, orientation and polarization of human breast cancer cells.
Ford LA; Roelofs AJ; Anavi-Goffer S; Mowat L; Simpson DG; Irving AJ; Rogers MJ; Rajnicek AM; Ross RA
Br J Pharmacol; 2010 Jun; 160(3):762-71. PubMed ID: 20590578
[TBL] [Abstract][Full Text] [Related]
6. 2-arachidonoylglycerol induces the migration of HL-60 cells differentiated into macrophage-like cells and human peripheral blood monocytes through the cannabinoid CB2 receptor-dependent mechanism.
Kishimoto S; Gokoh M; Oka S; Muramatsu M; Kajiwara T; Waku K; Sugiura T
J Biol Chem; 2003 Jul; 278(27):24469-75. PubMed ID: 12711605
[TBL] [Abstract][Full Text] [Related]
7. GPR55 Antagonist CID16020046 Protects against Atherosclerosis Development in Mice by Inhibiting Monocyte Adhesion and Mac-1 Expression.
Lee SJ; Im DS
Int J Mol Sci; 2021 Dec; 22(23):. PubMed ID: 34884889
[TBL] [Abstract][Full Text] [Related]
8. GPR55, a lysophosphatidylinositol receptor with cannabinoid sensitivity?
Nevalainen T; Irving AJ
Curr Top Med Chem; 2010; 10(8):799-813. PubMed ID: 20370712
[TBL] [Abstract][Full Text] [Related]
9. Endothelin-2 is a macrophage chemoattractant: implications for macrophage distribution in tumors.
Grimshaw MJ; Wilson JL; Balkwill FR
Eur J Immunol; 2002 Sep; 32(9):2393-400. PubMed ID: 12207323
[TBL] [Abstract][Full Text] [Related]
10. NEURONAL DEVELOPMENT. Glycerophospholipid regulation of modality-specific sensory axon guidance in the spinal cord.
Guy AT; Nagatsuka Y; Ooashi N; Inoue M; Nakata A; Greimel P; Inoue A; Nabetani T; Murayama A; Ohta K; Ito Y; Aoki J; Hirabayashi Y; Kamiguchi H
Science; 2015 Aug; 349(6251):974-7. PubMed ID: 26315437
[TBL] [Abstract][Full Text] [Related]
11. The G protein-coupled receptor 55 ligand l-α-lysophosphatidylinositol exerts microglia-dependent neuroprotection after excitotoxic lesion.
Kallendrusch S; Kremzow S; Nowicki M; Grabiec U; Winkelmann R; Benz A; Kraft R; Bechmann I; Dehghani F; Koch M
Glia; 2013 Nov; 61(11):1822-31. PubMed ID: 24038453
[TBL] [Abstract][Full Text] [Related]
12. GPR55-dependent stimulation of insulin secretion from isolated mouse and human islets of Langerhans.
Liu B; Song S; Ruz-Maldonado I; Pingitore A; Huang GC; Baker D; Jones PM; Persaud SJ
Diabetes Obes Metab; 2016 Dec; 18(12):1263-1273. PubMed ID: 27561953
[TBL] [Abstract][Full Text] [Related]
13. Peroxisome proliferator-activated receptor and retinoid X receptor ligands inhibit monocyte chemotactic protein-1-directed migration of monocytes.
Kintscher U; Goetze S; Wakino S; Kim S; Nagpal S; Chandraratna RA; Graf K; Fleck E; Hsueh WA; Law RE
Eur J Pharmacol; 2000 Aug; 401(3):259-70. PubMed ID: 10936484
[TBL] [Abstract][Full Text] [Related]
14. Preference for Glucose over Inositol Headgroup during Lysolipid Activation of G Protein-Coupled Receptor 55.
Guy AT; Kano K; Ohyama J; Kamiguchi H; Hirabayashi Y; Ito Y; Matsuo I; Greimel P
ACS Chem Neurosci; 2019 Jan; 10(1):716-727. PubMed ID: 30346710
[TBL] [Abstract][Full Text] [Related]
15. Lysophosphatidylinositol causes neurite retraction via GPR55, G13 and RhoA in PC12 cells.
Obara Y; Ueno S; Yanagihata Y; Nakahata N
PLoS One; 2011; 6(8):e24284. PubMed ID: 21904624
[TBL] [Abstract][Full Text] [Related]
16. The Lysophosphatidylinositol Receptor GPR55 Modulates Pain Perception in the Periaqueductal Gray.
Deliu E; Sperow M; Console-Bram L; Carter RL; Tilley DG; Kalamarides DJ; Kirby LG; Brailoiu GC; Brailoiu E; Benamar K; Abood ME
Mol Pharmacol; 2015 Aug; 88(2):265-72. PubMed ID: 25972448
[TBL] [Abstract][Full Text] [Related]
17. Human recombinant macrophage inflammatory protein-1 alpha and -beta and monocyte chemotactic and activating factor utilize common and unique receptors on human monocytes.
Wang JM; Sherry B; Fivash MJ; Kelvin DJ; Oppenheim JJ
J Immunol; 1993 Apr; 150(7):3022-9. PubMed ID: 8454871
[TBL] [Abstract][Full Text] [Related]
18. The differential characterization of GPR55 receptor in human peripheral blood reveals a distinctive expression in monocytes and NK cells and a proinflammatory role in these innate cells.
Chiurchiù V; Lanuti M; De Bardi M; Battistini L; Maccarrone M
Int Immunol; 2015 Mar; 27(3):153-60. PubMed ID: 25344934
[TBL] [Abstract][Full Text] [Related]
19. Endocannabinoid content in fetal bovine sera - unexpected effects on mononuclear cells and osteoclastogenesis.
Marazzi J; Kleyer J; Paredes JM; Gertsch J
J Immunol Methods; 2011 Oct; 373(1-2):219-28. PubMed ID: 21920367
[TBL] [Abstract][Full Text] [Related]
20. GPR55 promotes migration and adhesion of colon cancer cells indicating a role in metastasis.
Kargl J; Andersen L; Hasenöhrl C; Feuersinger D; Stančić A; Fauland A; Magnes C; El-Heliebi A; Lax S; Uranitsch S; Haybaeck J; Heinemann A; Schicho R
Br J Pharmacol; 2016 Jan; 173(1):142-54. PubMed ID: 26436760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
